Virtus ETF Advisers LLC Taysha Gene Therapies, Inc. Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 31,597 shares of TSHA stock, worth $51,819. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,597
Previous 22,103
42.95%
Holding current value
$51,819
Previous $44,000
22.73%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding TSHA
# of Institutions
130Shares Held
151MCall Options Held
48KPut Options Held
7.8K-
Avoro Capital Advisors LLC New York, NY20MShares$32.8 Million0.5% of portfolio
-
Morgan Stanley New York, NY17.6MShares$28.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$19.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$17.8 Million0.3% of portfolio
-
Octagon Capital Advisors LP New York, NY10.5MShares$17.1 Million4.03% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $79.3M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...